Healthcare and Biotech Data Rooms
Efficiently bring new technologies, cures and treatments to market by securely collaborating within a healthcare, life sciences or biotech data room.
Healthcare Data Rooms by Venue for Clinical Research, Licensing, M&A, and Fundraising
Keep highly sensitive documentation safe throughout the research & development process as well as various business lifecycles, while accessing our team of experts for 24/7/365 support.
Sharing large pharma data sets across 50 global sites supports diverse collaborations worldwide
How Venue’s high security and collaborative design delivered for biopharma
Virtual data rooms that solve complex challenges for healthcare transactions
Multi-file Redaction
Easy Set Up
Security
Reporting & Analytics
Power a More Efficient Workflow
AI Contract Analytics
15 minutes is plenty of time to see if Venue is a fit for your team.
or
call +1 800 823 5304
Venue checks the security boxes
Venue secure healthcare, life sciences and biotech data rooms accelerate critical business moments. The DFIN Information Security Program helps to ensure data protection, enterprise cybersecurity and supply chain security using multiple standards, including:
SOC2 Type II Audits
ISO/IEC 27001:2013 Certification
MFA & SSO Integration
AES 256-bit Encryption at Rest & in Transit
3rd Party Penetration Testing
Role-based Access Control (RBAC)
Intrusion Prevention (IPS) and Detection (IDS) Systems
Frequently asked questions
VDRs help facilitate the deal-making process from fundraising to IPO and beyond, keeping information secure and ensuring a smooth transition. They are also used during clinical trials to protect sensitive information and keep it confidential.
Your platform should have the ability to categorize due diligence documents including intellectual property, financial information, customer information, and more. It should also feature controls for proper user access and data storage.
The number of merger and acquisition deals in the industry has risen dramatically in recent years. Also, FDA approval standards are becoming more stringent, and more pharmaceutical and biotech companies are looking for new ways to reduce their operating costs.